Meliolabs Inc.

Santa Clara, CA

UEI
MEHHH8HCNVB3
CAGE
84QG2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3108 Patrick Henry Dr, Santa Clara, CA 95054, USA
Website
melio.tech
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract subawards

Prime contractor Prime award Amount Awarded
Trustees Of Boston University CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA Melio is committed to revolutionizing the healthcare industry by offering rapid infectious disease diagnostic… 75A50122C00028 $1,436,243

Grant awards

Award Agency Obligated Awarded
A rapid test for congenital syphilis screening R41HD107895 National Institute of Child Health and Human Development (NIH) $599,782
Rapid and broad pathogen profiling system for infection in newborn R43AI145567 National Institute of Allergy and Infectious Diseases (NIH) $299,732

Quick answers

Is Meliolabs Inc. registered in SAM.gov?

Yes. Meliolabs Inc.'s SAM.gov registration is active through February 12, 2027.

What is Meliolabs Inc.'s most recent federal award?

Meliolabs Inc.'s most recent federal grant award is A rapid test for congenital syphilis screening (R41HD107895), from National Institute of Child Health and Human Development (NIH), on September 19, 2022.

On GovTribe

See Meliolabs Inc.'s full federal record

  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login